Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2026 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with...
March 23, 2026 08:00 ET | Source: Amphista Therapeutics

Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs

Cambridge, UK, 23rd March 2026 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three...
March 23, 2026 07:30 ET | Source: FuelCell Energy, Inc.

FuelCell Energy Scales Up for Data Centers with Packaged 12.5 MW Utility‑Grade Power Block Solution and Manufacturing Expansion Plans

DANBURY, Conn., March 23, 2026 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (NASDAQ: FCEL) is taking significant steps toward meeting the speed of delivery and surging demand of data centers for...
March 23, 2026 07:17 ET | Source: VALNEVA

Pfizer et Valneva annoncent que le candidat vaccin contre la maladie de Lyme démontre une forte efficacité dans l’essai de Phase 3 VALOR

Le candidat vaccin PF-07307405 (LB6V) a démontré une efficacité de plus de 70 % dans la prévention de la maladie de Lyme chez les personnes âgées de cinq ans et plus.Le candidat vaccin a été bien...
March 23, 2026 07:00 ET | Source: Algernon Health Inc.

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that it will be...
March 23, 2026 07:00 ET | Source: Pyxis Oncology

Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first...
March 23, 2026 05:32 ET | Source: Columbus A/S

Indkaldelse til ordinær generalforsamling

Selskabsmeddelelse nr. 25/2026 I henhold til vedtægternes pkt. 9.1 indkaldes til ordinær generalforsamling i Columbus A/S: Torsdag den 23. april 2026 kl. 10.00 hos Columbus, Lautrupvang 6, 2750...
March 23, 2026 05:32 ET | Source: Columbus A/S

Notice to convene Annual General Meeting

Company announcement no. 25/2026 According to Art. 9.1 of the Articles of Association, notice is hereby given of the Annual General Meeting of Columbus A/S to be held on: Thursday 23 April 2026 at...
March 23, 2026 05:00 ET | Source: Anaveon

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

Anaveon, a late-stage biotech company, appoints Thaminda Ramanayake as its new Chief Executive Officer.
March 23, 2026 03:15 ET | Source: Ilkka Oyj

Ilkka Oyj:n hallitus suosittaa, että osakkeenomistajien ehdotus koskien osakesarjojen yhdistämistä ja suunnattua maksutonta osakeantia hyväksytään varsinaisessa yhtiökokouksessa

Ilkka Oyj Pörssitiedote 23.3.2026, klo 9.15ILKKA OYJ:N HALLITUS SUOSITTAA, ETTÄ OSAKKEENOMISTAJIEN EHDOTUS KOSKIEN OSAKESARJOJEN YHDISTÄMISTÄ JA SUUNNATTUA MAKSUTONTA OSAKEANTIA...